Pamplona Capital has acquired Loparex from Intermediate Capital Group which acquired the company in March 2015.
Loparex is a manufacturer of silicone release liners which are used in applications in the medical, industrial, tapes, graphics, hygiene, label and composites sectors. Release liners are designed specifically to stick to an adhesive material without fusing so that it can be easily pulled away from the adhesive-backed materials without compromising the adhesive. Simple industry examples include bandages and postage stamps. Release paper can be made with a 1- or 2-sided coating and they can be made with various degrees of release, thickness, and size.
Loparex, led by CEO Simon Medley, is headquartered in Cary, NC and Apeldoorn, The Netherlands and has three manufacturing facilities in the US, one in Europe and one in China (www.loparex.com).
“Loparex is well placed for future growth and we firmly believe that Pamplona is the right partner to support us as we accelerate our market-driven strategy to create significant value for both the company and its customers,” said Mr. Medley.
Pamplona makes direct private equity and fund of funds investments. The firm manages over $12 billion in assets across several funds for a variety of clients including public pension funds, international wealth managers, multinational corporations, family offices, and funds of hedge funds. Pamplona was founded in 2005 and is based in London and New York (www.pamplonafunds.com).
“Over the last 113 years, Loparex has established itself as a leader in the silicone release liners market, with a strong reputation for in-depth technical expertise and industry-leading production technology,” said Paul MacDuff, a partner at Pamplona. “We look forward to working with the Loparex management team to solidify and build on this position going forward.”
“Pamplona has a proven track record in accelerating the development and expansion of manufacturing companies, and we are looking forward to bringing Loparex’s expertise and products to an even wider global market,” said Martin Schwab and William Pruellage, co-managing partners at Pamplona, in a released statement.
Pamplona’s investment in Loparex was made from its fifth private equity fund, Pamplona Capital Partners V LP, a $3.2 billion fund which was raised in 2017.
Intermediate Capital Group (LSE: ICP), the seller of Loparex, is an alternative asset manager investing in private debt, credit and equity. The firm has more than €38 billion of assets under management and is headquartered in London with additional offices across the UK, US, Europe, and Asia Pacific (www.icgam.com).
© 2019 Private Equity Professional | August 5, 2019
